Insider Cluster (3 insiders) ·Filed Jun 10, 2026

MIRM

Mirum Pharmaceuticals, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed3mo ago
Insider cluster: 3 insiders, $0.9M total
Actionable Insight • Neutral

Insider sales are immaterial in dollar terms and likely reflect routine diversification and option exercise tax planning. No bearish signal from this cluster. Monitor next earnings for fundamental updates; the 95% analyst buy rating and strong historical performance suggest continued positive sentiment.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
MIRM ▲ +7.05% at T+60d
NEUTRAL call ✓ call won +7.05% · α vs SPY +0.47% · entry $94.00 → $100.63
Entry anchored
Jun 9, 03:59 PM ET
via exchange tick
T+1d
+5.89%
call +5.89% · α +4.19%
$99.54
settled 4mo ago
T+5d
+8.03%
call +8.03% · α +4.60%
$101.55
settled 4mo ago
T+20d
+35.85%
call +35.85% · α +32.23%
$127.70
settled 3mo ago
T+60d
+7.05%
call +7.05% · α +0.47%
$100.63
settled 29d ago

Price Chart

Loading chart...

Executive Summary

Three Mirum insiders, including the CEO and CFO, sold a total of $854K in open-market sales over a one-week window. The CFO also exercised and sold shares from option exercises, while the COO exercised options without selling. The sales represent ~0.015% of the $5.7B market cap, well below the 0.1% threshold for materiality, and the cluster includes a mix of cashless exercises and open-market sales, suggesting routine portfolio management rather than a coordinated bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$854.0K
Insiders
3

Key Facts

  • CEO Christopher Peetz sold 2.6K shares for $246K on 2026-06-01
  • Director Saira Ramasastry sold 4.0K shares for $398K on 2026-06-01
  • CFO Eric Bjerklolt sold 2.3K shares for $210K on 2026-06-08, following option exercises
  • Total open-market sales: $854K, representing ~0.015% of market cap
  • COO Peter Radovich exercised 16,988 options on 2026-06-05 but did not sell any shares

Financial Impact

Total insider sales of $854K, or ~0.015% of $5.7B market cap — trivial relative to company size

insider ownershipdilution

Risk Factors

  • Insider sales, while small, could be misinterpreted by retail traders as a negative signal
  • The CEO and CFO both sold, which may raise questions if followed by larger sales

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (19 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-MIRM-1781054493725
16 reports for MIRM
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+20▲ +28.29%Jun 11, 2026
Filters
Rows
Reports for MIRM — sortable, filterable
TypeNow
Aug 19, 2026
6w ago
Insider Cluster
NEUTRAL ★ 3/10
$102.24 $98.82▼ −3.35%▼ −1.39%$82.93 (−18.89%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$98.97 $100.61▲ +1.66%▲ +3.55%$82.93 (−16.21%)
Aug 11, 2026
7w ago
Insider Cluster
BEARISH ★ 5/10
$98.97 $100.61▼ −1.66%▼ −3.55%$82.93 (+16.21%)
Aug 10, 2026
7w ago
144
NEUTRAL ★ 3/10
$98.23 $98.30▲ +0.07%▲ +1.13%$82.93 (−15.58%)
Aug 5, 2026
8w ago
8-K
MIXED ★ 6/10
$94.12 $100.63▲ +6.92%▲ +6.32%$82.93 (−11.88%)
Jul 8, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$128.57 $105.79▼ −17.72%▼ −20.99%$82.93 (−35.50%)
Jun 11, 2026
16w ago
Institutional Cluster
BULLISH ★ 6/10
$99.54 $127.70▲ +28.29%▲ +26.40%$82.93 (−16.69%)
Jun 10, 2026
16w ago
Insider Cluster
NEUTRAL ★ 3/10
$94.00 $127.70▲ +35.85%▲ +32.23%$82.93 (−11.78%)
Jun 2, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$91.84 $125.59▲ +36.76%▲ +37.76%$82.93 (−9.70%)
Jun 1, 2026
17w ago
144
NEUTRAL ★ 3/10
$92.17 $120.46▲ +30.69%▲ +32.26%$82.93 (−10.02%)
Showing 10 of 16

US Market Status

Market Closed — Opens Mon (65h 25m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 10, 2026